Tag: mhra
Navigating Mass Injury Claims: A Guide to Group Action Compensation
This guide explores what mass injury claims entail and steps to pursue them, and how our firm can support you in securing the compensation you deserve.
When large-scale incidents cause widespread harm, pursuing a mass injury claim through a group action can be an effective way to seek justice and fair compensation. The Group Action Lawyers specialises in guiding individuals through the complexities of these claims, ensuring victims’ voices are amplified through collective action.
Understanding Standards and Regulations Around Cosmetic Procedures
In the wake of growing concerns over the safety and oversight of aesthetic treatments, the UK Parliament’s Women and Equalities Committee (WEC) has been actively scrutinising the industry. This inquiry highlights critical issues in standards and regulations around cosmetic procedures, shedding light on how lapses can lead to serious health impacts.
As specialists in collective legal claims, The Group Action Lawyers is here to help those affected pursue justice through group actions, where multiple claimants join forces for stronger representation and potential compensation.
Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall
A recall of Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation suspension by CD Pharma Ltd has highlighted a labelling error. This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA.
The Group Action Lawyers specialises in helping affected individuals pursue compensation through group actions when pharmaceutical errors like this occur. This article explores the details of the recall and how people might be eligible to generally claim compensation in such circumstances.
Patient Information Leaflet Problems: Your Right to Compensation
Failure in the patient information leaflet problems can potentially endanger countless patients who depend on medications for treatment.
In May 2025, the Medicines and Healthcare Products Regulatory Agency (MHRA) issued a critical Class 4 Medicines Notification concerning multiple topical steroid products manufactured by Chemidex Pharma Ltd. The core issue lies in the patient information leaflets (PILs) included with these medications, which reportedly omitted vital safety information about potential side effects, specifically visual disturbances such as blurred vision or other ocular complications.
The absence of accurate information in patient information leaflets can have far-reaching consequences, as patients rely on these documents to understand the risks associated with their medications.
Multiple Injuries Legal Action: Claiming Compensation with The Group Action Lawyers
If you have experienced harm alongside others due to negligence or misconduct, you may be eligible to join a multiple injuries legal action.
When multiple individuals suffer injuries from the same event or source, pursuing compensation through a group action can be an effective way to achieve justice. The Group Action Lawyers specialise in managing complex group claims, ensuring victims receive the compensation they deserve.
Press-In-Bottle-Adaptor Issue – MHRA In The News
A recent MHRA alert has brought a Press-In-Bottle-Adaptor issue into sharp focus, raising concerns about the safety and effectiveness of certain medicines.
Specifically, the issue reportedly affects Mycophenolate Mofetil 1g/5ml Oral Suspension, a medication crucial for patients undergoing organ transplantation or managing autoimmune conditions.
At The Group Action Lawyers, we are experts in cases involving defective products and medicines. We are here to support victims of defects, helping them claim compensation for any harm caused.
Vaginal Mesh Degrades: Claiming Compensation in a Group Action
Whilst implants were initially introduced as a solution for pelvic organ prolapse and stress urinary incontinence, their widespread use has led to reports of severe complications when the vaginal mesh degrades.
The controversy surrounding vaginal mesh implants has brought to light the devastating potential impact these devices have had on the lives of countless women. These complications can be life-altering, and many patients are now seeking justice through legal action.
At The Group Action Lawyers, we are committed to helping victims claim the compensation they deserve.
CPT Hip System Femoral Stem MHRA Matter
If you have experienced complications following surgery involving the CPT Hip System Femoral Stem, the matter was recently highlighted in a recent MHRA alert.
Patients with this medical device potentially face some risks, and The Group Action Lawyers are assessing the situation.
Philips Respironics Ventilators: MHRA Matters In The News
The recent Field Safety Notice involving Philips Respironics ventilators has raised concerns, perhaps particularly among patients who may rely on these devices for critical respiratory support.
The Medicines and Healthcare products Regulatory Agency (MHRA) issued an alert concerning issues in the use of Philips Respironics BiPAP A-Series ventilators, which could lead to therapy interruptions.
Legency Remedies Eye Wash Recall
The safety of medical products is paramount, especially when they are meant to address critical health needs. We look at the Legency Remedies eye wash recall.
When products like eye wash solutions are recalled due to safety concerns, individuals who have used them may face unforeseen health risks. If you have suffered as a result of such issues, you may be entitled to compensation.
At The Group Action Lawyers, we specialise in helping individuals navigate the complexities of group action claims arising from product recalls.